MED SOC AD Adam Blum · CancerBot ctDNA Trials in Breast Cancer: How TREAT ctDNA, DARE and Apollo Are Changing Early Intervention And Why CancerBot’s Precision Trial Matching Is Becoming Even More Important Than Ever
MED TCH DR Dr. Aarti Darra Decoding Cancer Without a Biopsy Molecular profiling of tumors has brought a new dawn in cancer diagnostics and treatment, however, the realization of this promise often…
MED GEN LA Larvol Clinic Prospective Biomarker Study on Prognostic Impact of ctDNA in Ewing Sarcoma and Osteosarcoma This is a prospective multicenter biomarker study evaluating the prognostic impact of ctDNA detection at diagnosis in patients with Ewing…
MDA MED SCI PH PHG Foundation Liquid biopsies in cancer The following is tidied up transcript from the Making science work for health podcast, produced by the PHG Foundation. This episode was…
MED AN Anchor Molecular Characterization of DNA-free Plasma and Its Usage as True Plasma-Based Quality Control Standards… Yabin Lu, Dan Luo, Alina Polonskaia, Anchor Molecular Inc. 7026 Koll Center Parkway, Suite 215, Pleasanton, CA 94566, U.S.A
MED IC ICR Using the seeds of cancer to guide treatment strategies In 1869, pathologist Thomas Ashworth noticed some unusual cells in the blood of a patient who had died of cancer. The cells didn’t look…